Ascendis Pharma A/S (ASND)
Every figure this model derived for ASND, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.
The figures, and where each came from
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 0 | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
2024-09-30 |
| cash | 616,041,000 | CashAndCashEquivalents |
2025-12-31 |
| current assets | 1,108,985,000 | CurrentAssets |
2025-12-31 |
| current liabilities | 1,069,391,000 | CurrentLiabilities |
2025-12-31 |
| equity | -162,821,000 | Equity |
2025-12-31 |
| interest expense | 206,688,000 | FinanceCosts |
2025-12-31 |
| ocf | 53,897,000 | CashFlowsFromUsedInOperatingActivities |
2025-12-31 |
| revenue | 720,133,000 | Revenue |
2025-12-31 |
| sbc | 116,171,000 | AdjustmentsForSharebasedPayments |
2025-12-31 |
The ratios
The figures themselves rather than their scores — what somebody looking up ASND on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | -0.4 |
| current ratio | 1.04 |
| current ratio reported | 1.04 |
| deferred revenue growth | 428.21 |
| dilution pct | 4.69 |
| ev owner earnings | -214.08 |
| ev sales | 18.51 |
| fcf margin | 7.48 |
| growth cv | 0.99 |
| interest cover | -0.66 |
| operating margin | -18.92 |
| owner earnings margin | -8.65 |
| revenue growth | 98.03 |
| revenue growth per share | 89.16 |
| roic | -20.61 |
| rule of 40 | 79.11 |
| sbc pct revenue | 16.13 |
Everything else this filing tags
210 more elements from ASND's own XBRL that this model has no measure for, newest reading each, largest first. Nothing here is converted, added up or renamed — it is the filing's own element names and the filing's own numbers.
| Element | Newest | As of | Periods | Unit |
|---|---|---|---|---|
Liabilities | 1,465,391,000 | 2025-12-31 | 67 | EUR |
Assets | 1,302,570,000 | 2025-12-31 | 67 | EUR |
EquityAndLiabilities | 1,302,570,000 | 2025-12-31 | 67 | EUR |
FinancialLiabilities | 1,219,720,000 | 2025-12-31 | 33 | EUR |
NonderivativeFinancialLiabilitiesUndiscountedCashFlows | 963,489,000 | 2025-12-31 | 8 | EUR |
LiabilitiesArisingFromFinancingActivities | 871,786,000 | 2025-12-31 | 12 | EUR |
CurrentFinancialLiabilities | 834,466,000 | 2025-12-31 | 28 | EUR |
FinancialAssets | 776,964,000 | 2025-12-31 | 28 | EUR |
CurrentFinancialAssets | 766,094,000 | 2025-12-31 | 28 | EUR |
Borrowings | 720,262,000 | 2025-12-31 | 14 | EUR |
RevenueFromSaleOfGoods | 683,572,000 | 2025-12-31 | 52 | EUR |
GrossProfit | 625,217,000 | 2025-12-31 | 55 | EUR |
AccountingProfit | -577,817,000 | 2022-12-31 | 18 | EUR |
BalancesWithBanks | 494,046,000 | 2025-06-30 | 16 | EUR |
SellingGeneralAndAdministrativeExpense | 457,867,000 | 2025-12-31 | 107 | EUR |
TaxEffectOfTaxLosses | 430,011,000 | 2025-12-31 | 24 | EUR |
ShorttermBorrowings | 429,391,000 | 2025-12-31 | 33 | EUR |
ShorttermDepositsClassifiedAsCashEquivalents | 427,810,000 | 2022-12-31 | 6 | EUR |
NoncurrentLiabilities | 396,000,000 | 2025-12-31 | 53 | EUR |
LongtermBorrowings | 385,254,000 | 2025-12-31 | 33 | EUR |
NoncurrentFinancialLiabilities | 385,254,000 | 2025-12-31 | 28 | EUR |
OtherCurrentFinancialLiabilities | 383,769,000 | 2025-12-31 | 17 | EUR |
EmployeeBenefitsExpense | 376,565,000 | 2025-12-31 | 27 | EUR |
ResearchAndDevelopmentExpense | 303,621,000 | 2025-12-31 | 107 | EUR |
Inventories | 301,533,000 | 2025-12-31 | 37 | EUR |
InventoriesTotal | 301,533,000 | 2025-12-31 | 9 | EUR |
DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised | 291,759,000 | 2025-12-31 | 9 | EUR |
DerivativeFinancialLiabilities | 256,231,000 | 2025-12-31 | 28 | EUR |
CurrentDerivativeFinancialLiabilities | 256,231,000 | 2025-12-31 | 17 | EUR |
WorkInProgress | 253,494,000 | 2025-12-31 | 9 | EUR |
ComprehensiveIncome | -231,572,000 | 2025-12-31 | 107 | EUR |
ComprehensiveIncomeAttributableToOwnersOfParent | -231,572,000 | 2025-12-31 | 107 | EUR |
ProfitLoss | -228,034,000 | 2025-12-31 | 103 | EUR |
ProfitLossAttributableToOwnersOfParent | -228,034,000 | 2025-12-31 | 76 | EUR |
ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects | -228,034,000 | 2025-12-31 | 7 | EUR |
WagesAndSalaries | 227,118,000 | 2025-12-31 | 27 | EUR |
ProfitLossBeforeTax | -212,651,000 | 2025-12-31 | 107 | EUR |
ReserveOfSharebasedPayments | 199,900,000 | 2021-12-31 | 2 | EUR |
ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity | -194,472,000 | 2025-09-30 | 8 | EUR |
NoncurrentAssets | 193,585,000 | 2025-12-31 | 67 | EUR |
NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts | 182,715,000 | 2025-12-31 | 14 | EUR |
CurrentProvisions | 166,396,000 | 2025-12-31 | 35 | EUR |
LeaseLiabilities | 151,524,000 | 2025-12-31 | 30 | EUR |
PropertyPlantAndEquipment | 146,479,000 | 2025-12-31 | 67 | EUR |
NoncurrentDerivativeFinancialLiabilities | 143,296,000 | 2023-12-31 | 19 | EUR |
IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities | -142,467,000 | 2022-12-31 | 2 | EUR |
CurrentTradeReceivables | 141,333,000 | 2025-12-31 | 60 | EUR |
ProfitLossFromOperatingActivities | -136,271,000 | 2025-12-31 | 107 | EUR |
ExpenseFromSharebasedPaymentTransactionsWithEmployees | 116,171,000 | 2025-12-31 | 27 | EUR |
IncreaseDecreaseThroughSharebasedPaymentTransactions | 116,171,000 | 2025-12-31 | 75 | EUR |
FinanceIncome | 113,999,000 | 2025-12-31 | 107 | EUR |
IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities | -99,177,000 | 2025-12-31 | 8 | EUR |
ProfitLossFromContinuingOperations | -98,119,000 | 2018-09-30 | 13 | EUR |
CostOfSales | 94,915,000 | 2025-12-31 | 55 | EUR |
TradeAndOtherPayables | 91,703,000 | 2025-12-31 | 19 | EUR |
TradeAndOtherCurrentPayablesToTradeSuppliers | 90,657,000 | 2025-12-31 | 59 | EUR |
IncreaseDecreaseThroughTransactionsWithOwners | 87,078,000 | 2025-12-31 | 72 | EUR |
ProceedsFromExerciseOfWarrants | 87,078,000 | 2025-12-31 | 39 | EUR |
NoncurrentLeaseLiabilities | 84,619,000 | 2023-12-31 | 28 | EUR |
IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges | 81,740,000 | 2025-12-31 | 75 | EUR |
InterestExpense | 80,647,000 | 2025-12-31 | 27 | EUR |
IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities | 78,517,000 | 2025-12-31 | 8 | EUR |
NetForeignExchangeGain | 78,229,000 | 2025-12-31 | 21 | EUR |
AdjustmentsForProvisions | 77,585,000 | 2025-12-31 | 36 | EUR |
NewProvisionsOtherProvisions | 74,288,000 | 2025-12-31 | 2 | EUR |
CashFlowsFromUsedInOperations | 68,209,000 | 2025-12-31 | 75 | EUR |
NumberOfSharesIssued | 61,977,408 | 2025-12-31 | 73 | shares |
WeightedAverageShares | 60,607,131 | 2025-12-31 | 107 | shares |
AdjustedWeightedAverageShares | 60,237,774 | 2025-06-30 | 11 | shares |
OtherCurrentLiabilities | 58,204,000 | 2025-12-31 | 37 | EUR |
NumberOfSharesOutstanding | 56,877,723 | 2021-09-30 | 21 | shares |
ReversalOfInventoryWritedown | 53,700,000 | 2021-12-31 | 1 | EUR |
TaxExpenseIncomeAtApplicableTaxRate | 46,783,000 | 2025-12-31 | 27 | EUR |
CashFlowsFromUsedInFinancingActivities | 36,328,000 | 2025-12-31 | 75 | EUR |
CurrentPrepayments | 33,715,000 | 2025-12-31 | 67 | EUR |
InvestmentsInAssociates | 32,526,000 | 2025-12-31 | 58 | EUR |
OtherCurrentPayables | 32,362,000 | 2021-09-30 | 22 | EUR |
TradeAndOtherCurrentPayables | 31,021,000 | 2018-09-30 | 8 | EUR |
RightofuseAssets | 30,900,000 | 2025-12-31 | 10 | EUR |
FinishedGoods | 28,956,000 | 2025-12-31 | 9 | EUR |
AdditionalProvisionsOtherProvisions | 28,293,000 | 2023-12-31 | 1 | EUR |
EffectOfExchangeRateChangesOnCashAndCashEquivalents | -25,242,000 | 2025-12-31 | 75 | EUR |
InventoryWritedown2011 | 24,900,000 | 2025-12-31 | 5 | EUR |
FinanceCostsPaidClassifiedAsOperatingActivities | 22,935,000 | 2025-12-31 | 69 | EUR |
RepaymentsOfBorrowingsClassifiedAsFinancingActivities | 21,958,000 | 2025-12-31 | 18 | EUR |
SocialSecurityContributions | 21,134,000 | 2025-12-31 | 27 | EUR |
AdditionsToRightofuseAssets | 20,200,000 | 2019-09-30 | 3 | EUR |
MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease | 19,627,000 | 2018-12-31 | 6 | EUR |
CurrentRawMaterialsAndCurrentProductionSupplies | 19,083,000 | 2025-12-31 | 9 | EUR |
PaymentsToAcquireOrRedeemEntitysShares | 17,396,000 | 2025-12-31 | 28 | EUR |
PurchaseOfTreasuryShares | 17,396,000 | 2025-12-31 | 16 | EUR |
AdjustmentsForDepreciationExpense | 17,206,000 | 2025-12-31 | 75 | EUR |
DepreciationPropertyPlantAndEquipment | 17,206,000 | 2025-12-31 | 27 | EUR |
ShorttermInvestmentsClassifiedAsCashEquivalents | 16,957,000 | 2022-12-31 | 5 | EUR |
ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod | 16,308,000 | 2025-12-31 | 86 | EUR |
ContractLiabilities | 16,100,000 | 2022-09-30 | 1 | EUR |
AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables | 15,588,000 | 2025-12-31 | 39 | EUR |
LossesOnChangeInFairValueOfDerivatives | 15,483,000 | 2022-12-31 | 2 | EUR |
CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods | -15,383,000 | 2025-12-31 | 27 | EUR |
IncomeTaxExpenseContinuingOperations | 15,383,000 | 2025-12-31 | 107 | EUR |
FinanceIncomeReceivedClassifiedAsOperatingActivities | 15,302,000 | 2025-12-31 | 69 | EUR |
RevenueFromInterest | 15,301,000 | 2025-12-31 | 27 | EUR |
GainsOnChangeInFairValueOfDerivatives | 14,654,000 | 2023-12-31 | 1 | EUR |
OtherCurrentReceivables | 14,582,000 | 2025-12-31 | 67 | EUR |
CurrentLeaseLiabilities | 14,174,000 | 2023-12-31 | 28 | EUR |
CurrentTaxExpenseIncome | -12,556,000 | 2025-12-31 | 27 | EUR |
DepreciationRightofuseAssets | 12,350,000 | 2025-12-31 | 18 | EUR |
RevenueFromRenderingOfServices | 11,794,000 | 2024-12-31 | 94 | EUR |
OtherNoncurrentReceivables | 10,870,000 | 2025-12-31 | 39 | EUR |
NoncurrentFinancialAssets | 10,870,000 | 2025-12-31 | 28 | EUR |
PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities | 10,438,000 | 2023-12-31 | 39 | EUR |
AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | -10,373,000 | 2025-12-31 | 75 | EUR |
IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions | -10,338,000 | 2025-12-31 | 3 | EUR |
TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures | 9,762,000 | 2025-12-31 | 6 | EUR |
TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss | 9,740,000 | 2024-12-31 | 24 | EUR |
GainsLossesOnChangeInFairValueOfDerivatives | 9,700,000 | 2022-09-30 | 5 | EUR |
NetDeferredTaxAssets | -9,623,000 | 2025-12-31 | 18 | EUR |
DeferredTaxLiabilities | 9,623,000 | 2025-12-31 | 19 | EUR |
DeferredTaxLiabilityAsset | -9,623,000 | 2025-12-31 | 3 | EUR |
AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities | 8,648,000 | 2022-12-31 | 12 | EUR |
CashFlowsFromUsedInInvestingActivities | -8,485,000 | 2025-12-31 | 75 | EUR |
OtherReceivables | 8,332,000 | 2020-12-31 | 2 | EUR |
IssuedCapital | 8,322,000 | 2025-12-31 | 67 | EUR |
ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment | 7,500,000 | 2025-09-30 | 3 | EUR |
ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets | 7,354,000 | 2024-03-31 | 28 | EUR |
PostemploymentBenefitExpenseDefinedBenefitPlans | 6,921,000 | 2025-12-31 | 27 | EUR |
IncomeTaxesPaidRefundClassifiedAsOperatingActivities | 6,679,000 | 2025-12-31 | 75 | EUR |
GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss | 6,533,000 | 2021-12-31 | 5 | EUR |
CashOutflowForLeases | 6,429,000 | 2021-12-31 | 5 | EUR |
CurrentTaxLiabilities | 6,427,000 | 2025-12-31 | 63 | EUR |
NumberOfInstrumentsOtherEquityInstrumentsGranted | 6,148,004 | 2020-12-31 | 1 | pure |
AdjustmentsForDecreaseIncreaseInPrepaidExpenses | -6,051,000 | 2025-12-31 | 39 | EUR |
AdjustmentsForDecreaseIncreaseInInventories | -5,920,000 | 2025-12-31 | 37 | EUR |
RestrictedCashAndCashEquivalents | 5,776,000 | 2019-12-31 | 16 | EUR |
LicenceFeeIncome | 5,630,000 | 2025-12-31 | 87 | EUR |
AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment | 5,283,000 | 2025-12-31 | 13 | EUR |
ValueAddedTaxReceivables | 5,276,000 | 2020-12-31 | 2 | EUR |
NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement | 5,222,591 | 2025-12-31 | 11 | pure |
OtherEmployeeExpense | 5,221,000 | 2025-12-31 | 9 | EUR |
CurrentContractLiabilities | 4,944,000 | 2025-12-31 | 57 | EUR |
OtherFinanceCost | 4,322,000 | 2022-12-31 | 1 | EUR |
InterestExpenseOnLeaseLiabilities | 4,186,000 | 2025-12-31 | 21 | EUR |
IncreaseDecreaseInExistingProvisionsOtherProvisions | 3,936,000 | 2025-12-31 | 2 | EUR |
IntangibleAssetsAndGoodwill | 3,710,000 | 2025-12-31 | 25 | EUR |
OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | -3,538,000 | 2025-12-31 | 107 | EUR |
OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax | -3,538,000 | 2025-12-31 | 107 | EUR |
Goodwill | 3,495,000 | 2020-03-31 | 22 | EUR |
DeferredTaxExpenseIncomeRecognisedInProfitOrLoss | -3,340,000 | 2025-12-31 | 3 | EUR |
DeferredTaxExpenseIncome | -3,092,000 | 2018-12-31 | 3 | EUR |
InterestReceivedClassifiedAsOperatingActivities | 2,919,000 | 2021-09-30 | 6 | EUR |
RentalExpense | 2,700,000 | 2018-12-31 | 6 | EUR |
OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome | -2,121,000 | 2025-12-31 | 27 | EUR |
CurrentTaxAssetsCurrent | 1,781,000 | 2025-12-31 | 59 | EUR |
LongtermDeposits | 1,713,000 | 2021-09-30 | 30 | EUR |
InterestPaidClassifiedAsFinancingActivities | 1,326,000 | 2021-12-31 | 2 | EUR |
IncreaseDecreaseInNumberOfOrdinarySharesIssued | 1,287,921 | 2025-12-31 | 19 | shares |
NoncurrentContractLiabilities | 1,123,000 | 2025-12-31 | 35 | EUR |
InterestPaidClassifiedAsOperatingActivities | 1,056,000 | 2021-09-30 | 6 | EUR |
AuditorsRemuneration | 851,000 | 2025-12-31 | 18 | EUR |
AuditorsRemunerationForAuditServices | 840,000 | 2025-12-31 | 18 | EUR |
AdjustmentsForIncreaseDecreaseInDepositsFromCustomers | -822,000 | 2018-06-30 | 7 | EUR |
AdjustmentsForDecreaseIncreaseInTradeAccountReceivable | 797,000 | 2020-03-31 | 20 | EUR |
CurrentAssetsLiabilities | 702,100 | 2020-12-31 | 1 | EUR |
IncomeTaxesPaidRefund | -700,000 | 2025-12-31 | 26 | EUR |
UnusedProvisionReversedOtherProvisions | 639,000 | 2025-12-31 | 1 | EUR |
AdjustmentsForCurrentTaxOfPriorPeriod | 513,000 | 2025-12-31 | 8 | EUR |
AdjustmentsForAmortisationExpense | 490,000 | 2025-12-31 | 39 | EUR |
DeferredIncome | 400,000 | 2020-12-31 | 6 | EUR |
AdjustmentsForIncreaseDecreaseInDeferredIncome | -327,000 | 2021-09-30 | 27 | EUR |
ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed | 285,000 | 2024-12-31 | 15 | EUR |
AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities | 131,000 | 2025-12-31 | 27 | EUR |
DeferredIncomeClassifiedAsCurrent | 94,000 | 2016-12-31 | 1 | EUR |
TreasuryShares | 80,000 | 2025-12-31 | 14 | EUR |
AdjustmentsForDeferredTaxOfPriorPeriods | 70,000 | 2025-12-31 | 6 | EUR |
OtherComprehensiveIncome | -37,000 | 2019-12-31 | 17 | EUR |
PaymentsForDevelopmentProjectExpenditure | 36,000 | 2024-09-30 | 22 | EUR |
AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables | 19,000 | 2019-09-30 | 18 | EUR |
AuditorsRemunerationForOtherServices | 13,000 | 2021-12-31 | 7 | EUR |
ConstructionInProgress | 1,900 | 2021-12-31 | 4 | EUR |
AverageNumberOfEmployees | 1,103 | 2025-12-31 | 27 | Employee |
WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 | 103 | 2025-12-31 | 9 | EUR/shares |
WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 | 70 | 2020-12-31 | 1 | EUR/shares |
WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 | 46 | 2019-12-31 | 1 | EUR |
WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement | 29 | 2018-12-31 | 4 | EUR |
BasicAndDilutedEarningsLossPerShare | -5 | 2021-09-30 | 45 | EUR/shares |
BasicEarningsLossPerShare | -4 | 2025-12-31 | 44 | EUR/shares |
DilutedEarningsLossPerShare | -4 | 2025-12-31 | 36 | EUR/shares |
ParValuePerShare | 1 | 2025-12-31 | 33 | DKK/shares |
ProportionOfOwnershipInterestInAssociate | 0 | 2021-12-31 | 2 | pure |
ApplicableTaxRate | 0 | 2025-12-31 | 27 | pure |
AverageEffectiveTaxRate | 0 | 2025-12-31 | 24 | pure |
AuditorsRemunerationForTaxServices | 0 | 2025-12-31 | 17 | EUR |
CurrentFinancialAssetsAvailableforsale | 0 | 2024-03-31 | 29 | EUR |
DividendPayables | 0 | 2018-12-31 | 2 | EUR |
ImpairmentLossRecognisedInProfitOrLossGoodwill | 0 | 2020-03-31 | 16 | EUR |
NetForeignExchangeLoss | 0 | 2025-12-31 | 15 | EUR |
NoncurrentFinancialAssetsAvailableforsale | 0 | 2023-12-31 | 26 | EUR |
OtherNoncurrentLiabilities | 0 | 2021-12-31 | 4 | EUR |
OtherNoncurrentPayables | 0 | 2021-09-30 | 9 | EUR |
PaymentsForShareIssueCosts | 0 | 2025-12-31 | 32 | EUR |
ProceedsFromIssuingShares | 0 | 2025-12-31 | 49 | EUR |
ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | 0 | 2025-12-31 | 19 | EUR |
ProvisionsForDoubtfulDebtsRelatedToOutstandingBalancesOfRelatedPartyTransaction | 0 | 2019-12-31 | 3 | EUR |
PurchaseOfAvailableforsaleFinancialAssets | 0 | 2023-12-31 | 28 | EUR |
PurchaseOfInterestsInAssociates | 0 | 2023-12-31 | 14 | EUR |
ProceedsFromBorrowingsClassifiedAsFinancingActivities | 0 | 2025-12-31 | 15 | EUR |
GainsLossesOnDisposalsOfPropertyPlantAndEquipment | 0 | 2025-12-31 | 20 | EUR |
ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities | 0 | 2025-12-31 | 16 | EUR |
PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities | 0 | 2024-12-31 | 3 | EUR |
DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares | 0 | 2025-06-30 | 4 | shares |
What to be careful about
What this model itself distrusts about ASND's figures. Written by the derivation as it ran, not added afterwards.
- no current capital expenditure tagged (last tagged 2024-09-30); treated as zero, so free cash flow is overstated and equals operating cash flow
- reports in EUR and quotes in USD, so the share price is converted at 1 USD = 0.8989 EUR as at 2026-10-14. Only the price is converted: every figure from the filing is as reported, and only the multiples built on market capitalisation carry the rate
- there is no operating profit to value; valuation rests on EV/revenue (18.5x) instead
- analyst estimate not used: trailing EPS is not positive, so a growth rate would be meaningless